Interventional Cardiology Devices Market by Device Types (Stents – Bare Metal, Bio-Absorbable, Drug Eluting; Catheters – Angiography, Guiding, IVUS, Pulmonary Arterial Catheters; PTCA Balloons – Normal, Drug Eluting, Cutting, Scoring; Imaging Systems – FFR, IVUS, OCT; PTCA Guidewires) and Forecast 2017-2021

Interventional Cardiology Devices Market by Device Types (Stents – Bare Metal, Bio-Absorbable, Drug Eluting; Catheters – Angiography, Guiding, IVUS, Pulmonary Arterial Catheters; PTCA Balloons – Normal, Drug Eluting, Cutting, Scoring; Imaging Systems – FFR, IVUS, OCT; PTCA Guidewires) and Forecast 2017-2021

Interventional cardiology devices are minimally invasive devices used in the detection and treatment of coronary artery disease. Interventional cardiology involves various non-surgical procedures for treating cardiovascular disease by using drug-eluting stents, bare-metal stents, percutaneous transluminal coronary angioplasty (PTCA) and cutting balloon catheters. Interventional cardiology is a minimally invasive catheter based technology that enables treatment of coronary artery disease (coronary blockages or narrowing of the coronary artery restricting normal blood flow). Rising incidences of coronary artery disease, increasing lifestyle disorders such as obesity and growing disposable income are primarily leading to increase in the number of percutaneous interventions.

The global interventional cardiology devices market report provides market size estimates (Revenue USD million – 2014 to 2021) for key market segments based on the type of device used (stents – bare metal, bio-absorbable, drug eluting; catheters – angiography, guiding, IVUS, pulmonary arterial catheters; PTCA balloons – normal, drug eluting, cutting, scoring; imaging systems such as FFR, IVUS, OCT; PTCA guidewires, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).

The global interventional cardiology devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global interventional cardiology devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global interventional cardiology devices market and included in this report are Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Medtronic, plc, St. Jude Medical, Inc., Smiths Medical, and Terumo Medical Corporation.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Interventional Cardiology Devices Market

1. Device Type
1.1. Stents
1.1.1. Bare Metal Stents
1.1.2. Bio-absorbable Stents
1.1.3. Drug-Eluting Stents
1.2. Catheters
1.2.1. Angiography Catheters
1.2.2. Guiding Catheters
1.2.3. Intravascular ultrasound (IVUS) Catheters
1.2.4. Pulmonary Artery Catheters
1.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
1.3.1. Cutting Balloons
1.3.2. Drug-eluting Balloons
1.3.3. Normal Balloons
1.3.4. Scoring Balloons
1.4. Imaging Systems
1.4.1. Fractional Flow Reserve (FFR)
1.4.2. Intravascular Ultrasound (IVUS)
1.4.3. Optical Coherence Tomography (OCT)
1.5. Percutaneous Transluminal Coronary Angioplasty Guidewires
1.6. Others

2. Company Profiles
2.1. Abbott Laboratories, Inc.
2.2. B. Braun Melsungen AG
2.3. Boston Scientific Corporation
2.4. Cook Medical, Inc.
2.5. Johnson & Johnson (Cordis Corporation)
2.6. Medtronic, Inc.
2.7. Smiths Medical
2.8. St. Jude Medical, Inc.
2.9. Terumo Corporation

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »